Published in Respir Res on May 15, 2007
Serum heat shock protein 47 levels are elevated in acute exacerbation of idiopathic pulmonary fibrosis. Cell Stress Chaperones (2013) 0.91
Blockade of advanced glycation end product formation attenuates bleomycin-induced pulmonary fibrosis in rats. Respir Res (2009) 0.86
Fibrocytes in the fibrotic lung: altered phenotype detected by flow cytometry. Front Pharmacol (2014) 0.83
Heat Shock Protein 27 Plays a Pivotal Role in Myofibroblast Differentiation and in the Development of Bleomycin-Induced Pulmonary Fibrosis. PLoS One (2016) 0.76
Serum heat shock protein 47 levels in patients with drug-induced lung disease. Respir Res (2013) 0.75
The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid. Arch Biochem Biophys (1961) 19.31
Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J Clin Pathol (1988) 5.16
Pharmacokinetics, biodistribution, and stability of oligodeoxynucleotide phosphorothioates in mice. Proc Natl Acad Sci U S A (1991) 2.76
Transient gene transfer and expression of Smad7 prevents bleomycin-induced lung fibrosis in mice. J Clin Invest (1999) 2.50
Release of biologically active TGF-beta1 by alveolar epithelial cells results in pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol (2003) 2.14
Hsp47: a collagen-specific molecular chaperone. Trends Biochem Sci (1996) 1.61
Involvement of the stress protein HSP47 in procollagen processing in the endoplasmic reticulum. J Cell Biol (1992) 1.50
Interactions between collagen-binding stress protein HSP47 and collagen. Analysis of kinetic parameters by surface plasmon resonance biosensor. J Biol Chem (1994) 1.48
pH-dependent function, purification, and intracellular location of a major collagen-binding glycoprotein. J Cell Biol (1987) 1.43
Intracellular interaction of collagen-specific stress protein HSP47 with newly synthesized procollagen. J Cell Biol (1996) 1.36
Expression and function of heat shock protein 47: a collagen-specific molecular chaperone in the endoplasmic reticulum. Matrix Biol (1998) 1.32
Treatment of bleomycin-induced pulmonary fibrosis by transfer of urokinase-type plasminogen activator genes. Hum Gene Ther (1999) 1.29
Coexpression of the collagen-binding stress protein HSP47 gene and the alpha 1(I) and alpha 1(III) collagen genes in carbon tetrachloride-induced rat liver fibrosis. J Clin Invest (1994) 1.25
Collagen-binding heat shock protein (HSP) 47 expression in anti-thymocyte serum (ATS)-induced glomerulonephritis. J Pathol (1997) 1.13
Increased expression of type VI collagen in lung fibrosis. Am J Respir Crit Care Med (1995) 1.11
Intratracheal injection of adenovirus containing the human MnSOD transgene protects athymic nude mice from irradiation-induced organizing alveolitis. Int J Radiat Oncol Biol Phys (1999) 1.11
Hsp47 and the translation-translocation machinery cooperate in the production of alpha 1(I) chains of type I procollagen. J Biol Chem (1994) 1.10
Mechanisms and mediators of pulmonary fibrosis. Crit Rev Immunol (2005) 1.08
Pulmonary fibrosis. Methods Mol Med (2005) 1.04
Prevention of bleomycin-induced pulmonary fibrosis after adenovirus-mediated transfer of the bacterial bleomycin resistance gene. J Clin Invest (1997) 1.02
Adenovirus-mediated decorin gene transfer prevents TGF-beta-induced inhibition of lung morphogenesis. Am J Physiol (1999) 1.02
Antisense oligonucleotides against collagen-binding stress protein HSP47 suppress collagen accumulation in experimental glomerulonephritis. Lab Invest (1998) 0.98
Current and future therapeutic approaches in idiopathic pulmonary fibrosis. Eur Respir J (2005) 0.94
Molecular mechanisms of and possible treatment strategies for idiopathic pulmonary fibrosis. Curr Pharm Des (2005) 0.92
Antisense oligonucleotides to NF-kappaB improve survival in bleomycin-induced pneumopathy of the mouse. Am J Respir Crit Care Med (2000) 0.88
The transformation-sensitive heat shock protein (hsp47) binds specifically to Fetuin. Biochem Biophys Res Commun (1989) 0.86
Expression of heat shock protein 47 is increased in remnant kidney and correlates with disease progression. Int J Exp Pathol (1998) 0.83
Private specificities can dominate the humoral response to self-antigens in patients with cryptogenic fibrosing alveolitis. Respir Res (2001) 0.80
Steroid and/or other immunosuppressive therapies in idiopathic interstitial pneumonias: have they still a role? Sarcoidosis Vasc Diffuse Lung Dis (2005) 0.79
Establishment of a model of atrial fibrillation associated with chronic kidney disease in rats and the role of oxidative stress. Heart Rhythm (2012) 1.77
Effects of an angiotensin-converting enzyme inhibitor on the inflammatory response in in vivo and in vitro models. Crit Care Med (2009) 1.71
Effects of hyperglycemia and insulin therapy on high mobility group box 1 in endotoxin-induced acute lung injury in a rat model. Crit Care Med (2008) 1.69
High dose antithrombin III inhibits HMGB1 and improves endotoxin-induced acute lung injury in rats. Intensive Care Med (2007) 1.63
Hyperglycemia contributes to cardiac dysfunction in a lipopolysaccharide-induced systemic inflammation model. Crit Care Med (2009) 1.44
New lipoic acid derivative drug sodium zinc dihydrolipoylhistidinate prevents cardiac dysfunction in an isolated perfused rat heart model. Crit Care Med (2011) 1.44
Anesthetic management of a patient with hyperthyroidism due to hydatidiform mole. J Anesth (2009) 1.15
Mechanisms of analgesic action of pulsed radiofrequency on adjuvant-induced pain in the rat: roles of descending adrenergic and serotonergic systems. Eur J Pain (2008) 1.09
Retracted Antithrombin reduces ischemia/reperfusion-induced renal injury in rats by inhibiting leukocyte activation through promotion of prostacyclin production. Blood (2002) 1.08
Antagonist of the type-1 ANG II receptor prevents against LPS-induced septic shock in rats. Intensive Care Med (2009) 1.02
Landiolol, an ultrashort-acting beta1-adrenoceptor antagonist, has protective effects in an LPS-induced systemic inflammation model. Shock (2009) 1.01
Pulmonary changes in a mouse model of combined burn and smoke inhalation-induced injury. J Appl Physiol (1985) (2008) 0.99
Effect of Ulinastatin, a human urinary trypsin inhibitor, on the oleic acid-induced acute lung injury in rats via the inhibition of activated leukocytes. Injury (2005) 0.98
Hydrogen-rich saline solution attenuates renal ischemia-reperfusion injury. J Anesth (2010) 0.97
Virus associated hemophagocytic syndrome accompanied by acute respiratory failure caused by influenza A (H3N2). Intern Med (2006) 0.97
C-reactive protein induces high-mobility group box-1 protein release through activation of p38MAPK in macrophage RAW264.7 cells. Cardiovasc Pathol (2007) 0.96
GaAlAs (830 nm) low-level laser enhances peripheral endogenous opioid analgesia in rats. Lasers Surg Med (2007) 0.95
A neutrophil elastase inhibitor, sivelestat, reduces lung injury following endotoxin-induced shock in rats by inhibiting HMGB1. Inflammation (2008) 0.93
The effect of landiolol on hemodynamics and left ventricular function in patients with coronary artery disease. J Clin Anesth (2007) 0.93
Pre-Irradiation of blood by gallium aluminum arsenide (830 nm) low-level laser enhances peripheral endogenous opioid analgesia in rats. Anesth Analg (2008) 0.92
Use of imaging agent to determine postoperative indwelling epidural catheter position. Korean J Pain (2010) 0.89
High-dose intravenous immunoglobulin G improves systemic inflammation in a rat model of CLP-induced sepsis. Intensive Care Med (2008) 0.89
Antiproliferative effects of a new α-lipoic acid derivative, DHL-HisZnNa, in HT29 human colon cancer cells in vitro. Expert Opin Ther Targets (2012) 0.89
ETS-GS, a new antioxidant, ameliorates renal ischemia-reperfusion injury in a rodent model. J Surg Res (2010) 0.89
[Th1/Th2 balance in systemic inflammatory response syndrome (SIRS)]. Nihon Rinsho (2004) 0.87
In vivo and in vitro effects of the anticoagulant, thrombomodulin, on the inflammatory response in rodent models. Shock (2010) 0.87
Adenosine diphosphate receptor antagonist clopidogrel sulfate attenuates LPS-induced systemic inflammation in a rat model. Shock (2011) 0.86
High mobility group box 1 induces a negative inotropic effect on the left ventricle in an isolated rat heart model of septic shock: a pilot study. Circ J (2008) 0.86
Age-dependent responses to renal ischemia-reperfusion injury. J Surg Res (2010) 0.85
An antisense oligonucleotide to HSP47 inhibits paraquat-induced pulmonary fibrosis in rats. Toxicology (2007) 0.85
Antithrombin III prevents cerulein-induced acute pancreatitis in rats. Pancreas (2009) 0.84
Danaparoid sodium inhibits systemic inflammation and prevents endotoxin-induced acute lung injury in rats. Crit Care (2008) 0.84
Stimulation of autophagy in the liver by lipopolysaccharide-induced systemic inflammation in a rat model of diabetes mellitus. Biomed Res (2010) 0.84
Retracted Coexpression of HSP47 gene and type I and type III collagen genes in LPS-induced pulmonary fibrosis in rats. Lung (2007) 0.84
Heat shock protein 72 protects insulin-secreting beta cells from lipopolysaccharide-induced endoplasmic reticulum stress. Int J Hyperthermia (2009) 0.83
Recombinant thrombomodulin prevents heatstroke by inhibition of high-mobility group box 1 protein in sera of rats. Shock (2010) 0.83
Change in free radical-related substances in plasma following ischemia-reperfusion in rat liver. Pathophysiology (2002) 0.83
Infusion of a glucose solution reduces autophagy in the liver after LPS-induced systemic inflammation. Inflammation (2012) 0.83
Conversion of atrial flutter to sinus rhythm during landiolol infusion. J Anesth (2009) 0.83
Nafamostat mesilate inhibits high-mobility group box 1 by lipopolysaccharide stimulation in murine macrophage RAW 264.7. Shock (2007) 0.82
Filtration leukocytapheresis therapy ameliorates lipopolysaccharide-induced systemic inflammation in a rat model. J Surg Res (2010) 0.82
Gabexate mesilate inhibits the expression of HMGB1 in lipopolysaccharide-induced acute lung injury. J Surg Res (2009) 0.82
Doripenem pharmacokinetics in critically ill patients receiving continuous hemodiafiltration (CHDF). Yakugaku Zasshi (2010) 0.82
The vitamin E derivative, EPC-K1, suppresses inflammation during hepatic ischemia-reperfusion injury and exerts hepatoprotective effects in rats. J Surg Res (2011) 0.81
Alternate day calorie restriction improves systemic inflammation in a mouse model of sepsis induced by cecal ligation and puncture. J Surg Res (2010) 0.81
High-dose antithrombin III prevents heat stroke by attenuating systemic inflammation in rats. Inflamm Res (2010) 0.81
A newly synthetic vitamin E derivative, E-Ant-S-GS, attenuates lung injury caused by cecal ligation and puncture-induced sepsis in rats. Surgery (2011) 0.81
Dihydrolipoyl histidinate zinc complex, a new antioxidant, attenuates hepatic ischemia-reperfusion injury in rats. J Gastroenterol Hepatol (2011) 0.81
Olprinone reduces ischemia/reperfusion-induced acute renal injury in rats through enhancement of cAMP. Shock (2005) 0.80
The effect of experimental diabetes on high mobility group box 1 protein expression in endotoxin-induced acute lung injury. J Surg Res (2009) 0.80
Retracted Continuous hemodiafiltration therapy ameliorates LPS-induced systemic inflammation in a rat model. J Surg Res (2010) 0.80
Antiviral effects of geranylgeranylacetone: enhancement of MxA expression and phosphorylation of PKR during influenza virus infection. Antimicrob Agents Chemother (2003) 0.80
Effect of enteral versus parenteral nutrition on inflammation and cardiac function in a rat model of endotoxin-induced sepsis. Shock (2008) 0.80
Window current through the T-type Ca2+ channel triggers the mechanism for cellular apoptosis via mitochondrial pathways. Heart Vessels (2013) 0.79
[Resistance to vecuronium bromide induced muscle relaxation in a patient with chronic renal failure and secondary hyperparathyroidism]. Masui (2007) 0.79